Durability and determinants of anti-SARS-CoV-2 spike antibodies following the second and third doses of mRNA COVID-19 vaccine

Shohei Yamamoto, Yusuke Oshiro, Natsumi Inamura, Takashi Nemoto, Kumi Horii, Kaori Okudera, Maki Konishi, Mitsuru Ozeki, Tetsuya Mizoue, Haruhito Sugiyama, Nobuyoshi Aoyanagi, Wataru Sugiura, Norio Ohmagari
doi: https://doi.org/10.1101/2022.11.07.22282054

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

Back to top
Posted November 08, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Durability and determinants of anti-SARS-CoV-2 spike antibodies following the second and third doses of mRNA COVID-19 vaccine
Shohei Yamamoto, Yusuke Oshiro, Natsumi Inamura, Takashi Nemoto, Kumi Horii, Kaori Okudera, Maki Konishi, Mitsuru Ozeki, Tetsuya Mizoue, Haruhito Sugiyama, Nobuyoshi Aoyanagi, Wataru Sugiura, Norio Ohmagari
medRxiv 2022.11.07.22282054; doi: https://doi.org/10.1101/2022.11.07.22282054
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area